Tarceva News and Research

RSS
Tarceva is a drug used to treat certain types of non-small cell lung cancer. It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. Tarceva is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called CP-358,774, erlotinib, erlotinib hydrochloride, and OSI-774.
Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound

Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound

Cancer stem cells may be at the root of brain tumors

Cancer stem cells may be at the root of brain tumors

Positive results for novel anti-cancer drug ECO-4601

Positive results for novel anti-cancer drug ECO-4601

DNA microarray chips improved therapy in some patients with incurable cancer

DNA microarray chips improved therapy in some patients with incurable cancer

Study suggests brain tumors need treatment with multiple 'targeted' drugs

Study suggests brain tumors need treatment with multiple 'targeted' drugs

Lung cancer patients taking Tarceva who develop a rash fair better

Lung cancer patients taking Tarceva who develop a rash fair better

Skin rash actually signifies better outcomes for pancreatic and lung cancer patients

Skin rash actually signifies better outcomes for pancreatic and lung cancer patients

Guidelines on skin reactions to Epidermal Growth Factor Receptor Inhibitors (EGFRIs)

Guidelines on skin reactions to Epidermal Growth Factor Receptor Inhibitors (EGFRIs)

Britain second rate when it comes to treating cancer sufferers

Britain second rate when it comes to treating cancer sufferers

Tarceva extends life of patients with pancreatic cancer

Tarceva extends life of patients with pancreatic cancer

New mechanism identified for resistance to targeted lung cancer drugs

New mechanism identified for resistance to targeted lung cancer drugs

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

New test identifies patients who benefit from targeted cancer drugs

New test identifies patients who benefit from targeted cancer drugs

"Smart bomb" cancer therapy combo effective

"Smart bomb" cancer therapy combo effective

Experimental treatment increases response rates in advanced lung cancer

Experimental treatment increases response rates in advanced lung cancer

Novel animal model of lung adenocarcinoma

Novel animal model of lung adenocarcinoma

Genzyme launches test to monitor Gleevec resistance

Genzyme launches test to monitor Gleevec resistance

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Gene mapping project promises new targeted cancer therapies

Gene mapping project promises new targeted cancer therapies